We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Regulators might put up an obstacle given the Swedish group’s sizeable footprint in the sector
Move for veterinary pharma company would represent one of biggest UK private equity deals this year
UK maker of animal medicine holds talks with Swedish buyout group EQT over a £4.6bn deal
Niche specialisms give veterinary drugmaker edge over larger rivals
UK specialist in veterinary products rides wave in spending by animal owners
FTSE 250 animal health group boosted by dealmaking and innovation
Small but resilient, this Cheshire company has in five years doubled revenues and tripled earnings
Shares’ biggest one-day drop suggests investors are easily spooked
UK veterinary specialist sees 28% year-on-year revenue growth
Companies analysis from our sister publication
Veterinary pharma group has pet project in emerging markets
The multibillion pound pet sector offers investors more than companionship
Positive wider market lifts FTSE 100 to highest in seven weeks
The winner of this award will be a company that has clearly demonstrated that success is not just a short-term phenomenon
Tobacco an income-generating industry? No, it’s is nasty and in terminal decline
Mining sector vulnerable to profit taking
International Edition
